mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.07 |
mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.07 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.07 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.07 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.08 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.08 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.08 |